How Much Did Sware Raise?
Funding & Key Investors

Sware has secured significant enterprise-level funding, with its total funding reaching $24.2M. The company recently announced a major strategic investment of $6M, underscoring its pivotal role in transforming compliance for regulated technology solutions within the life sciences sector. This latest capital infusion is expected to accelerate Sware's mission to make Computer System Validation (CSV) processes paperless, seamless, and stressless.

What is Sware?

Sware
SoftwareHealthcare Software

Sware is dedicated to mitigating risks for patients by revolutionizing how the life sciences industry manages the compliance of regulated technology solutions. Recognizing that traditional Computer System Validation (CSV) methods have remained largely unchanged for over two decades, Sware's singular vision is to modernize this critical process. The company aims to deliver a paperless, seamless, and stressless experience for its clients, thereby enhancing efficiency and ensuring robust regulatory adherence in a rapidly evolving technological landscape.

How much funding has Sware raised?

Sware has raised a total of $24.2M across 3 funding rounds:

2021

Other Financing Round

$3.2M

2022

Series A

$15M

2024

Series B

$6M

Other Financing Round (2021): $3.2M, investors not publicly disclosed

Series A (2022): $15M led by Insight Partners, New Stack Ventures, and LRVHealth

Series B (2024): $6M supported by LRVHealth, New Stack Ventures, and First Analysis

Key Investors in Sware

LRVHealth

LRVHealth is a venture capital firm focused on disruptive digital health, devices, and diagnostic companies, indicating a strategic interest in Sware's life sciences compliance technology.

New Stack Ventures

New Stack Ventures is an early-stage venture capital firm that targets startups in under-capitalized markets, suggesting a belief in Sware's innovative approach and market potential.

First Analysis

First Analysis Securities, a venture capital firm, provides private equity investments in sectors including health care and software, aligning with Sware's focus on regulated technology solutions in life sciences.

What's next for Sware?

With the recent major strategic investment, Sware is poised for significant expansion and innovation. The company's focus on modernizing CSV processes positions it to capture a larger share of the life sciences compliance market. Future developments are likely to include further technological advancements to its platform, expanding its service offerings, and strengthening its market presence through strategic partnerships and increased sales and marketing efforts. This capital will fuel Sware's growth trajectory, enabling it to solidify its leadership in providing efficient and compliant technology solutions.

See full Sware company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Security SoftwareSoftware
Business Intelligence (BI) SoftwareSoftwareBusiness ServicesSoftware Testing
Business Intelligence (BI) SoftwareSoftwareMobile App Development
Security SoftwareSoftware

Frequently Asked Questions Regarding Sware Financial Insights

What are the most recent funding rounds that Sware has completed, and what were the funding rounds?
Sware has recently completed 3 funding rounds: Series B on Jun 6, 2024, Series A on Feb 9, 2022, Other Financing Round on Jun 1, 2021.
What is the total amount of funding Sware has raised to date?
Sware has raised a total of $24.2M in funding to date.
How many funding rounds has Sware completed?
Sware has completed 3 funding rounds.
How much funding did Sware raise in its most recent funding round?
Sware raised $6M in its most recent funding round.
Who are the lead investors in Sware's latest funding round?
The lead investor in Sware's latest funding round was LRVHealth. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Sware's history?
The largest funding round in Sware's history was $15M.
See more information about Sware